je.st
news
Phase 2 Study Results for Tivantinib in Combination with Cetuximab...
2013-06-02 05:10:54| Biotech - Topix.net
ArQule, Inc. today announced final data from a randomized, placebo-controlled, double-blind, Phase 2 clinical trial with tivantinib in combination with cetuximab and irinotecan in patients with relapsed or refractory KRAS wild-type metastatic colorectal cancer .
Tags: with
results
study
combination
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||